: In September 2025 , the Omnicare subsidiary filed for bankruptcy protection following significant legal penalties related to opioid dispensing.
: To provide CVS with a new dispensing channel for seniors and chronic care patients in assisted living and long-term care facilities.
By late 2022, CVS began categorizing Omnicare as "no longer a strategic asset" due to financial losses and legal challenges.
: Approximately $12.9 billion, which included $10.4 billion in cash ($98 per share) and the assumption of $2.3 billion in debt.
: On April 1, 2026 , Omnicare announced an asset purchase agreement with GenieRx Holdings LLC , serving as the "stalking horse bidder" in a court-supervised auction.
: The deadline for competing bids for Omnicare's assets is April 30, 2026 , with a potential auction scheduled for May 5, 2026 . Service Information
